18:10 , Sep 15, 2017 |  BC Week In Review  |  Company News

Wuxi gains commercialization rights to Tozaride in China from Andarix

Andarix Pharmaceuticals Inc. (Somerville, Mass.) granted Wuxi Fortune Pharmaceutical Co. Ltd. (Wuxi, China) commercialization rights in China for Tozaride to treat "lung and other cancers." Andarix said the companies will collaborate on clinical development of...
07:00 , Aug 11, 2014 |  BC Week In Review  |  Clinical News

Tozaride regulatory update

Andarix said FDA granted Orphan Drug designation to Tozaride to treat pancreatic cancer. The radiolabeled somatostatin peptide analog also has Orphan Drug designation in the U.S. to treat small cell lung cancer (SCLC). Andarix said...